Previous Close | 7.01 |
Open | 7.11 |
Bid | 6.97 x 900 |
Ask | 7.49 x 1300 |
Day's Range | 7.11 - 7.43 |
52 Week Range | 5.66 - 9.82 |
Volume | |
Avg. Volume | 157,425 |
Market Cap | 545.496M |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | 34.72 |
EPS (TTM) | 0.21 |
Earnings Date | Mar 02, 2022 - Mar 07, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Department of Defense (DoD) awarded a contract to SIGA for the procurement of up to approximately $7.5 million of oral TPOXX, of which approximately $3.6 million of oral TPOXX is targeted for delivery in 2022 and the remainder is subject to an option at the sole discretion of the DoD. SIGA has been
- First Sale of Intravenous (IV) TPOXX® to U.S. Government under the 19C BARDA Contract – - Contract with a New International Jurisdiction for an Initial Order of Approximately $3 Million of Oral TPOXX - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2022. “SIGA’s first quarter financia
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special dividend of $0.45 per share on the common stock of the Company. The special dividend is payable on June 2, 2022 to shareholders of record at the close of business on May 17, 2022. Phil Gomez, CEO of SIGA, commented, “Based on the Company’s current cash resources and its strong balance sheet, we believe